Novus Biotechnology Fund
Novus Biotechnology Fund 1 is an investment partnership with offices in Kalamazoo, Michigan and suburban Chicago. The purpose of the targeted $10 million fund is to achieve significant, long-term capital appreciation for its investors through investments in early stage biotech companies. The fund will focus on innovative solutions having a positive economic impact on health care expenditures; technologies which will not only have clinical utility but ultimately lower healthcare costs for the system as a whole.
Frank Saltiel, MDGeneral Partner, Novus Biotechnology Fund
Greg SchultzGeneral Partner, Novus Biotechnology Fund
Kevin McLeodManaging Director, OOB Michigan Medical Device Consortium
Stages of Investment
Sectors of Investment